Medical weight loss is evolving rapidly. More and more patients in Quebec are turning to medications such as Ozempic, Wegovy, Mounjaro, and Zepbound.

At the same time, bariatric surgery — particularly sleeve gastrectomy and gastric bypass — remains the most effective option for significant and long-lasting weight loss¹.

So, which option is best? And more importantly, how do you choose based on your situation?

How Do Weight Loss Medications Work?

Medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work primarily by regulating hunger hormones. They reduce appetite, increase feelings of fullness, and slow gastric emptying, leading to lower food intake without constant restriction².

In clinical practice, the results are meaningful: approximately 10–15% weight loss with semaglutide³, and up to 15–22% with tirzepatide⁴. While these outcomes are impressive, they need to be understood within the broader context of long-term treatment.

Limitations of Weight Loss Medications 

One of the most important considerations is that these treatments require ongoing use. When the medication is discontinued, the biological drivers of hunger return, and weight regain is common⁵.

To explore this further: What Is Bariatric Surgery? A Complete Guide for Patients in Canada

Additionally, although the results are clinically significant, they are generally less substantial than those achieved with bariatric surgery in patients with more severe obesity¹.

In Quebec, these medications are also typically paid out-of-pocket, with high monthly costs and limited access through public coverage depending on eligibility criteria.

Bariatric Surgery: A More Comprehensive Approach 

Bariatric surgery works through a combination of reduced food intake, hormonal changes, and significant metabolic effects, which explains its superior long-term effectiveness⁶.

Learn more: What Is Bariatric Surgery? A Complete Guide for Patients in Canada

Sleeve gastrectomy involves removing approximately 70–80% of the stomach, resulting in a significant reduction in hunger and an average loss of 50–60% of excess body weight⁷.

Gastric bypass, by reducing stomach size and altering the digestive pathway, leads to even greater weight loss — approximately 60–70% of excess weight — along with strong metabolic effects, particularly for conditions like type 2 diabetes⁸.

Learn more about life after surgery: Recovery and Life After Bariatric Surgery

Medications vs Surgery: What’s the Real Difference? 

The most notable difference between these approaches lies in the magnitude and durability of weight loss. Medications typically result in a 10–22% reduction in total body weight³⁴, whereas bariatric surgery leads to approximately 20–35% total weight loss⁷.

Durability is another key factor. Medications remain effective only while they are being taken, whereas surgery provides long-term effects due to lasting physiological changes⁶.

Additionally, the hormonal impact of surgery is more profound, contributing to greater appetite suppression and improved metabolic regulation.

A Combined Approach Is Increasingly Common

In modern practice, medications and surgery are no longer viewed as opposing options, but rather as complementary tools. Medications may be used before surgery to reduce operative risk, or after surgery to help manage plateaus or weight regain¹⁰.

This integrated approach allows for more personalized care and often leads to better long-term outcomes.

Which Option Is Best for You? 

The right choice depends on your clinical profile, your goals, and your preferences.

Medications may be appropriate for individuals with mild to moderate obesity or for those who prefer to avoid surgery, provided they are comfortable with long-term treatment.

Bariatric surgery is generally recommended for individuals with more severe obesity or obesity-related conditions such as diabetes, hypertension, or sleep apnea, particularly when other approaches have not been successful¹.

The Reality in Quebec 

In Quebec, bariatric surgery is available through the public healthcare system, but wait times can be significant. The private sector offers much faster access, often within a few weeks.

Weight loss medications, on the other hand, are usually paid privately, which can strongly influence decision-making.

Summary 

Medications such as Ozempic, Wegovy, Mounjaro, and Zepbound represent a major advancement in obesity treatment. However, bariatric surgery — whether sleeve gastrectomy or gastric bypass — remains the most effective and durable option for significant weight loss¹.

In many cases, a combined approach offers the best opportunity for long-term success¹⁰.

Not Sure Whether to Choose Medication or Bariatric Surgery? 

Every situation is unique. A medical evaluation can help determine your eligibility, set realistic expectations, and identify the most effective strategy for your needs.

Contact our team for a personalized evaluation at our private clinic in Quebec.
You can also meet with our bariatric nurse at no cost and with no obligation before seeing the surgeon.

References 

1. American Society for Metabolic and Bariatric Surgery (ASMBS) – Outcomes of bariatric surgery
2. Wilding JPH et al. New England Journal of Medicine, 2021
3. STEP Trials – Semaglutide clinical trial program
4. Jastreboff AM et al. New England Journal of Medicine, 2022 (SURMOUNT-1)
5. Rubino D et al. Diabetes, Obesity and Metabolism, 2021
6. Mechanisms of bariatric surgery – Endocrine Reviews
7. Courcoulas AP et al. JAMA / The Lancet – bariatric surgery outcomes
8. Schauer PR et al. New England Journal of Medicine – bariatric surgery and diabetes
9. ASMBS Clinical Guidelines – perioperative safety
10. Obesity Reviews – combined GLP-1 and bariatric surgery approaches